ES8708134A1 - Un procedimiento para la preparacion de derivados de homocisteina-tiolactona - Google Patents

Un procedimiento para la preparacion de derivados de homocisteina-tiolactona

Info

Publication number
ES8708134A1
ES8708134A1 ES552281A ES552281A ES8708134A1 ES 8708134 A1 ES8708134 A1 ES 8708134A1 ES 552281 A ES552281 A ES 552281A ES 552281 A ES552281 A ES 552281A ES 8708134 A1 ES8708134 A1 ES 8708134A1
Authority
ES
Spain
Prior art keywords
preparation
pharmaceutical compositions
homocysteine thiolactone
compositions therefrom
thiolactone derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES552281A
Other languages
English (en)
Other versions
ES552281A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chiesi Farmaceutici SpA
Original Assignee
Chiesi Farmaceutici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farmaceutici SpA filed Critical Chiesi Farmaceutici SpA
Publication of ES552281A0 publication Critical patent/ES552281A0/es
Publication of ES8708134A1 publication Critical patent/ES8708134A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/36—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

PROCEDIMIENTO DE OBTENCION DE DERIVADOS DE HOMOCISTEINA-TIOLACTONA. COMPRENDE: A) HACER REACCIONAR UN COMPUESTO DE FORMULA (II) CON OTRO DE FORMULA (III) O (IV), EN DISOLVENTE APOLAR APROTICO, POLAR APROTICO, O POLAR PROTICO, ENTRE 0JC Y LA TEMPERATURA DE REFLUJO DEL DISOLVENTE, DURANTE 1 A 10 HORAS, PARA OBTENER UN COMPUESTO DE FORMULA (I); Y B) TRATAR EL COMPUESTO OBTENIDO EN A) CON UNA CANTIDAD EQUIVALENTE DE BASES ORGANICAS O INORGANICAS, EN MEDIO POLAR, PARA OBTENER SALES FARMACEUTICAMENTE ACEPTABLES. SIENDO: A, RESIDUO SATURADO MONO O BICICLICO Y OTROS, OPCIONALMENTE SUSTITUIDO CON GRUPO ALQUILO Y OTROS; Y R, H, ALQUILO DE C 1 A 4 Y OTROS. SE UTILIZAN COMO MUCOSECRETOLITICOS, ANTIINFLAMATORIOS O HEPATOPROTECTORES.
ES552281A 1985-02-22 1986-02-21 Un procedimiento para la preparacion de derivados de homocisteina-tiolactona Expired ES8708134A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8519621A IT1215238B (it) 1985-02-22 1985-02-22 Derivati di omocisteina tiolattone,loro procedimento di preparazione e formulazioni farmaceutiche

Publications (2)

Publication Number Publication Date
ES552281A0 ES552281A0 (es) 1987-09-16
ES8708134A1 true ES8708134A1 (es) 1987-09-16

Family

ID=11159747

Family Applications (1)

Application Number Title Priority Date Filing Date
ES552281A Expired ES8708134A1 (es) 1985-02-22 1986-02-21 Un procedimiento para la preparacion de derivados de homocisteina-tiolactona

Country Status (8)

Country Link
US (1) US4690944A (es)
EP (1) EP0192191B1 (es)
JP (1) JPS61227579A (es)
AT (1) ATE42287T1 (es)
DE (1) DE3662887D1 (es)
ES (1) ES8708134A1 (es)
IT (1) IT1215238B (es)
PT (1) PT82071B (es)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2061398A1 (es) * 1993-03-02 1994-12-01 Prodesfarma Sa Procedimiento de obtencion de n-acetil homocisteina tiolactona a partir del dl-homocistina por metodos electroquimicos.
ES2061397A1 (es) * 1993-03-02 1994-12-01 Prodesfarma Sa Procedimiento de obtencion de n-acetil homocisteina tiolactona a partir de nn-acetil homocistina por metodos electroquimicos.

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254530B (it) * 1992-03-18 1995-09-25 Derivati mercapto acetamidici
US5237057A (en) * 1992-04-06 1993-08-17 Biosite Diagnostics, Inc. Tetrahydrocannabinol derivatives and protein and polypeptide tetrahydrocannabinol derivative conjugates and labels
US5274122A (en) * 1992-10-15 1993-12-28 Merck & Co., Inc. Acidic derivatives of homocysteine thiolactone

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2129877B1 (es) * 1971-03-18 1974-08-02 Fuveau Sa
FR2265355B1 (es) * 1974-03-28 1977-11-04 Blum Jean
IT1068217B (it) * 1976-10-14 1985-03-21 Sigma Tau Ind Farmaceuti Omocisteina tiolattone 6 cloro nicotinamide
FR2502153A1 (fr) * 1981-03-19 1982-09-24 Rech Pharmaceutiq Medicale Acides (2-oxo-3-tetrahydrothienylcarbamoyl)-alkylthio) acetiques, leurs sels et leurs esters, leur procede de preparation et les compositions pharmaceutiques en contenant

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2061398A1 (es) * 1993-03-02 1994-12-01 Prodesfarma Sa Procedimiento de obtencion de n-acetil homocisteina tiolactona a partir del dl-homocistina por metodos electroquimicos.
ES2061397A1 (es) * 1993-03-02 1994-12-01 Prodesfarma Sa Procedimiento de obtencion de n-acetil homocisteina tiolactona a partir de nn-acetil homocistina por metodos electroquimicos.

Also Published As

Publication number Publication date
PT82071B (pt) 1987-12-30
IT8519621A0 (it) 1985-02-22
IT1215238B (it) 1990-01-31
DE3662887D1 (en) 1989-05-24
US4690944A (en) 1987-09-01
JPH0322878B2 (es) 1991-03-27
ATE42287T1 (de) 1989-05-15
JPS61227579A (ja) 1986-10-09
EP0192191B1 (en) 1989-04-19
ES552281A0 (es) 1987-09-16
EP0192191A1 (en) 1986-08-27
PT82071A (en) 1986-03-01

Similar Documents

Publication Publication Date Title
GR3005315T3 (es)
HU906402D0 (en) Process for producing tricyclic carbapeneme derivatives an pharmaceutical preparatives containing these compounds as active substance
DE3760532D1 (en) Benzoûb¨thiophene and benzoûb¨furancarboxamide derivatives, processes for their preparation and therapeutical agents containing them
HUT40633A (en) Process for production of bicyclically condensated derivatives of oxasole and triasole-amin,substituated by 4-piperimidil-alkyl group
IS3452A7 (is) Efni afleidd af acyl og aðferð til framleiðslu þeirra
AU6516986A (en) New 3-oxadiazole and 3-carboxylic acid ester beta-carboline derivatives, their production and their use as drugs
IL81801A0 (en) Heteroaryloxy-beta-carboline derivatives,processes for their preparation and pharmaceutical compositions containing the same
IL86080A (en) Substituted alkoxy-2-alkyl-indan and 1,2,3,4-tetrahydro-naphthol,process for the preparation thereof and pharmaceutical compositions comprising the same
ES460286A1 (es) Un procedimiento de preparacion de espiro(1,3-dioxolan-4,3) quinuclidina.
ES8708134A1 (es) Un procedimiento para la preparacion de derivados de homocisteina-tiolactona
PT84716A (en) Process for the preparation of insecticidal compositions containing six-membered heterocyclic derivatives of n:-substituted-n,n:-diacylhydrazines
EP0270093A3 (en) Lactam derivatives, processes for the preparation thereof, pharmaceutical compositions comprising the same, and the use of such derivatives for the manufacture of a medicament having valuable therapeutic properties
PH23411A (en) 1,6-naphthyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing them
PT84718A (en) Process for the preparation of insecticidal compositions containing five-membered heterocyclic derivatives of n:-substituted-n,n:-diacylhydrazines
DE3267188D1 (en) Hydroxybenzylamino-aryl compounds, process for preparing and pharmaceutical compositions containing the same
EP0222371A3 (en) Thiazolidine derivatives, process for their preparation and pharmaceutical compositions
AU597923B2 (en) 5-aminoalkyl-beta-carboline derivatives, their production and their use as drugs
DE3270516D1 (en) Thiophene derivative having a mucoregulating and anticough activity, process for its preparation and pharmaceutical compositions containing it
EP0155006A3 (en) Compounds having antibacterial activity, process for their preparation and pharmaceutical compositions containing them
ES8305751A1 (es) Procedimiento para la obtencion de derivados del ditiol-1,2 ilideno-3 amonio.
JPS51133271A (en) Process for preparing heterocyclic compounds
AU553765B2 (en) Biologically active heterocyclic hydroximidates and thiolhydroximidates and carbamate ester derivatives thereof
ES8105713A1 (es) Un procedimiento para la preparacion de los enatiomeros levogiro y dextrogiro de la 1-ciclopropil-metil-4-(3-metoxi-5h- dibenzo (a,d) ciclohepten-5-iliden) piperidina
PT84005A (en) 6h-isoxazol]3,4-d"pyrazolo]3,4-b"pyridines a process and intermediates for their preparation and their use as medicaments

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970303